Description
SWOT ANALYSIS OF AVENTIS
Aventis
Parent Company
Aventis
Category
Pharmaceutical
Sector
Healthcare
Tagline/ Slogan
Creating a symphony of success
After merger with Sanofi it has become world’s largest pharmaceutical USP company
STP
Segment
Cardiovascular, CNS, diabetes, thrombosis, oncology
Target Group
Healthcare professionals, doctors & hospitals
Positioning
World class pharmaceutical manufacturer
SWOT Analysis
1. Strong brand building capabilities 2. Six blockbuster products which feature in top 110 brands 3. Broad portfolio of anti-diabetic drugs 4. Acquisition of well known brands of UMPL Strength 5. Sturdy and stable financial position
1. Largely dependent on Indian market for revenue generation 2. Limited presence in emerging markets 3. Its parent company Sanofi has laid off quite a few employees which Weakness has generated lot of negative publicity for company
1. Strong growth of Indian pharmaceutical market 2. Increasing health awareness Opportunity 3. Increasing number of diabetic patients
1. Increasing price pressures Threats 2. high inflation in Indian market
3. Global economic slowdown
Competition
1. Sun pharmaceuticals 2. Novartis 3. Cipla Competitors 4. Pfizer
doc_626669642.docx
SWOT ANALYSIS OF AVENTIS
Aventis
Parent Company
Aventis
Category
Pharmaceutical
Sector
Healthcare
Tagline/ Slogan
Creating a symphony of success
After merger with Sanofi it has become world’s largest pharmaceutical USP company
STP
Segment
Cardiovascular, CNS, diabetes, thrombosis, oncology
Target Group
Healthcare professionals, doctors & hospitals
Positioning
World class pharmaceutical manufacturer
SWOT Analysis
1. Strong brand building capabilities 2. Six blockbuster products which feature in top 110 brands 3. Broad portfolio of anti-diabetic drugs 4. Acquisition of well known brands of UMPL Strength 5. Sturdy and stable financial position
1. Largely dependent on Indian market for revenue generation 2. Limited presence in emerging markets 3. Its parent company Sanofi has laid off quite a few employees which Weakness has generated lot of negative publicity for company
1. Strong growth of Indian pharmaceutical market 2. Increasing health awareness Opportunity 3. Increasing number of diabetic patients
1. Increasing price pressures Threats 2. high inflation in Indian market
3. Global economic slowdown
Competition
1. Sun pharmaceuticals 2. Novartis 3. Cipla Competitors 4. Pfizer
doc_626669642.docx